NRXS
Neuraxis, Inc.
NYSE MKT: NRXS · HEALTHCARE · BIOTECHNOLOGY
$7.44
-2.23% today
Updated 2026-04-29
Market cap
$93.54M
P/E ratio
—
P/S ratio
26.21x
EPS (TTM)
$-0.95
Dividend yield
—
52W range
$2 – $8
Volume
0.2M
Neuraxis, Inc. (NRXS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-218.60%
Operating margin
-177.30%
ROE
-285.40%
ROA
-80.60%
Debt/equity
0.21x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $1.93M | $-3.73M | 75.08% | -213.48% | -193.04% |
| 2021 | $2.72M | $-3.03M | 82.81% | -109.14% | -111.27% |
| 2022 | $2.68M | $-4.78M | 88.94% | -125.61% | -178.05% |
| 2023 | $2.46M | $-14.63M | 87.67% | -270.91% | -594.57% |
| 2024 | $2.69M | $-8.24M | 86.52% | -266.46% | -306.84% |
| 2025 | $3.57M | $-7.80M | 84.23% | -219.37% | -218.55% |